CTA
FLGT icon

Colonial Trust Advisors’s Fulgent Genetics FLGT Stock Holding History

Colonial Trust Advisors’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-27
Closed -$587 – 716
2024
Q3 		$587 Hold
27
– – ﹤0.01% 719
2024
Q2 		$530 Hold
27
– – ﹤0.01% 718
2024
Q1 		$586 Hold
27
– – ﹤0.01% 898
2023
Q4 		$781 Hold
27
– – ﹤0.01% 791
2023
Q3 		$722 Hold
27
– – ﹤0.01% 796
2023
Q2 		$1K Hold
27
– – ﹤0.01% 794
2023
Q1 		$843 Hold
27
– – ﹤0.01% 803
2022
Q4 		$804 Buy
+27
New +$966 ﹤0.01% 810

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Colonial Trust Advisors's FLGT Position: Q4 2024 in Review

Colonial Trust Advisors sold out of Fulgent Genetics (FLGT) in Q4 2024, closing a stake of 27 shares — an estimated $587 sold.

Colonial Trust Advisors first reported a position in FLGT in Q4 2022 and held it in 8 quarters. The position peaked at $1K in Q2 2023. 189 funds tracked by Wall St. Rank hold FLGT as of Q4 2024.

  • Colonial Trust Advisors reported no remaining Fulgent Genetics position as of Q4 2024 after selling out during the quarter.
  • Colonial Trust Advisors sold 27 Fulgent Genetics shares in Q4 2024, an estimated $587.
  • Colonial Trust Advisors first reported a position in Fulgent Genetics in Q4 2022 and held it in 8 quarters.
  • Colonial Trust Advisors's Fulgent Genetics position peaked at $1K in Q2 2023.
  • 189 funds tracked by Wall St. Rank held Fulgent Genetics as of Q4 2024.

Based on Colonial Trust Advisors's 13F filing for Q4 2024, filed 13 Feb 2025.